Journal
VACCINES
Volume 10, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/vaccines10050788
Keywords
SARS-CoV-2; booster; third vaccination; BNT162b2; ChAdOx1-nCoV-19; T cell response; antibody concentration
Categories
Funding
- Deutsche Krebshilfe [70113532, 02/2020-01/2023]
Ask authors/readers for more resources
This study investigated the influence of previous vaccination on the immune response to the booster. The results showed that the choice of previous vaccines did not affect the outcome of the booster vaccination, and antibody concentrations increased over time after vaccination.
Emerging numbers of SARS-CoV-2 infections are currently combated with a third vaccination. Considering the different vaccination regimens used for the first two vaccine doses, we addressed whether the previous vaccination influences the immune response to the booster. Participants for this prospective study were recruited from among healthcare workers. N = 20 participants were previously vaccinated with two doses of BNT162b2, and n = 53 received a priming dose of ChAdOx1-nCoV-19 followed by a BNT162b2 dose. Participants were vaccinated with a third dose of BNT162b2 in December 2021. Antibody concentrations were determined after vaccination, and in a subset of n = 19 participants, T cell responses were evaluated. Anti-S concentrations and IFN gamma production increased during the first 21 days. The choice of the first and second vaccineshad no influence on the final outcome of the booster vaccination. Before booster vaccination, antibody concentrations were lower for older participants but increased more strongly over time.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available